Sector revisions Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. Other stock markets 03/07/2026			5-day change	1st Jan Change
186.01 ^CHF	+0.40%		+9.05%	-

02/07	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
01/07	Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Visibility	Nbr of analysts
LONZA GROUP AG			23
REVOLUTION MEDICINES, INC.			22
IQVIA HOLDINGS INC.			19
BEONE MEDICINES AG			27
CELLTRION, INC.			24
ASCENDIS PHARMA A/S	-		18
MEDPACE HOLDINGS, INC.			12
EUROFINS SCIENTIFIC SE			14
IONIS PHARMACEUTICALS, INC.			23
ICON PUBLIC LIMITED COMPANY			16
ABIVAX			6
BIO-TECHNE CORPORATION			12
TEMPUS AI, INC.			16
APOGEE THERAPEUTICS, INC.			12
KYMERA THERAPEUTICS, INC.			21
ALKERMES PLC			16
PRAXIS PRECISION MEDICINES, INC.			18
PROTAGONIST THERAPEUTICS, INC.			13
BLUEPRINT MEDICINES CORPORATION		-	-
Average			17
Weighted average by Cap.			19